Atara Biotherapeutics, Inc. Gains 92.82%
Thu, May 07, 2026 at 07:46 PM
Atara Biotherapeutics, Inc. (ATRA:NASDAQ) jumped higher at $9.93, a gain of 92.8%. On Thu, May 07, 2026, ATRA:NASDAQ touched a New 2-Week High of $9.93. The stock appeared on our News Catalysts scanner on Thu, May 07, 2026 at 12:05 PM in the 'BIOTECH' category. From Thu, Apr 23, 2026, the stock recorded 50.00% Up Days and 63.64% Green Days
The stock spiked on Thu, May 07, 2026 at $12.43 with a volume of 75M+.
About Atara Biotherapeutics, Inc. (ATRA:NASDAQ)
Atara Biotherapeutics Inc is engaged in the development of pharmaceutical products. Its focus lies on developing therapies addressing serious-life threatening diseases in the United States.
Top 10 Gainers:
- agilon health, inc. (AGL:NYSE), 117.81%
- Atara Biotherapeutics, Inc. (ATRA:NASDAQ), 92.82%
- Republic Power Group Ltd (RPGL:NASDAQ), 69.74%
- Rackspace Technology, Inc. (RXT:NASDAQ), 55.07%
- Global Engine Group Holding Limited (GLE:NASDAQ), 52.08%
- Banzai International, Inc. (BNZI:NASDAQ), 44.71%
- Fluence Energy, Inc. (FLNC:NASDAQ), 39.9%
- Xometry, Inc. (XMTR:NASDAQ), 39.18%
- Alpha Pro Tech, Ltd. (APT:NYSEMKT), 37.87%
- Real Messenger Corporation (RMSG:NASDAQ), 35.61%